Department of Oral Surgery, Hironokogen Hospital, 3-1-1 Kitayamadai Nishi-ku Kobe-shi, Hyogo 6512215, Japan.
Department of Oral and Maxillofacial Surgery, Aichi Medical University, 1-1 Yazakokarimata Nagakute-shi, Aichi 4801103, Japan.
Int J Environ Res Public Health. 2019 Sep 4;16(18):3248. doi: 10.3390/ijerph16183248.
This systematic review clarifies the amount of effective protrusion in mandibular advancement devices of oral appliances required for obstructive sleep apnea (OSA). The systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Review Manager 5 and GRADEpro were used to combine trials and analyze data. The present review included three studies. In mild to moderate OSA cases, measured using the apnea-hypopnea index (AHI), 50% protrusion was more effective than 75% protrusion. However, 75% protrusion was more effective for severe cases. Sleep stage, Epworth Sleepiness Scale (ESS), snoring index, and side effects significantly differed between the groups. Additionally, 75% protrusion was more effective (AHI: 0.38, 95% CI: -0.89 to 1.65, = 0.56; sleep stage 3: -1.20, 95% CI: 9.54-7.14, = 0.78; ESS: 1.07, 95% CI: -0.09 to 2.24, = 0.07; snoring index: 0.09, 95% CI: 0.05-0.13, < 0.05; side effects: RR: 1.89, 95% CI: 0.36-9.92, = 0.45). As per the AHI, 75% protrusion was effective in severe cases, whereas 50% protrusion was effective in moderate cases. Analysis of different surrogate outcomes indicated that 75% protrusion was more effective. Further, well-designed, larger trials should determine the benefits for patients. Additionally, investigations of adherence and side effects with long-term follow-up are needed.
本系统评价阐明了口腔矫治器下颌前伸装置治疗阻塞性睡眠呼吸暂停(OSA)所需的有效前伸量。系统评价遵循了系统评价和荟萃分析的首选报告项目(PRISMA)指南。使用 Review Manager 5 和 GRADEpro 来合并试验并分析数据。本综述包括三项研究。在使用呼吸暂停低通气指数(AHI)测量的轻中度 OSA 病例中,50%的前伸量比 75%的前伸量更有效。然而,75%的前伸量对重度病例更有效。睡眠阶段、Epworth 嗜睡量表(ESS)、打鼾指数和副作用在组间有显著差异。此外,75%的前伸量更有效(AHI:0.38,95%CI:-0.89 至 1.65, = 0.56;睡眠阶段 3:-1.20,95%CI:9.54 至 7.14, = 0.78;ESS:1.07,95%CI:-0.09 至 2.24, = 0.07;打鼾指数:0.09,95%CI:0.05 至 0.13, < 0.05;副作用:RR:1.89,95%CI:0.36 至 9.92, = 0.45)。根据 AHI,75%的前伸量对重度病例有效,而 50%的前伸量对中度病例有效。对不同替代结局的分析表明,75%的前伸量更有效。此外,需要进行设计良好、更大规模的试验来确定对患者的益处。还需要进行长期随访的依从性和副作用调查。